MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS
Main Authors: | María Cristina Ortega, Isabel Machin-Diaz, Michelle Naughton, Inmaculada Pérez-Molina, Jennifer García-Arocha, Jose Manuel García-Domínguez, Haydee García-Briceño, Rafael Lebron-Galan, Virginia Vila-Del Sol, Victor Quintanero-Casero, Rosa García-Montero, Victoria Galan, Leticia Calahorra, Celia Camacho-Toledano, Maria Luisa Martinez-Gines, Denise Fitzgerald, Diego Clemente |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123005638 |
Similar Items
-
EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
by: Mari Paz Serrano-Regal, et al.
Published: (2023-10-01) -
CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS
by: Mari Paz Serrano-Regal, et al.
Published: (2023-10-01) -
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
by: Celia Camacho-Toledano, et al.
Published: (2022-11-01) -
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
by: Carolina Melero-Jerez, et al.
Published: (2020-07-01) -
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis
by: Carolina Melero-Jerez, et al.
Published: (2019-07-01)